157 Intranasal delivery of liposomal saccharide-linked diethyldithiocarbamates: formulation development and free drug assessment
The treatment success of Glioblastoma (GBM) remains poor, with lack of success being attributed to both the presence of the blood-brain barrier and chemoresistance. The development of intranasal delivery alongside the use of a novel anticancer agent could provide a more direct and successful route to the brain wi...